Pharmaceutical Preparations

"Pharmaceutical Preparations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.

Descriptor ID	D004364
MeSH Number(s)	D26
Concept/Terms	Pharmaceutical Preparations Pharmaceutical Preparations Pharmaceutic Preparations Preparations, Pharmaceutic Preparations, Pharmaceutical Drugs Pharmaceutical Products Products, Pharmaceutical

Below are MeSH descriptors whose meaning is more general than "Pharmaceutical Preparations".

Chemicals and Drugs [D]
Pharmaceutical Preparations [D26]

Below are MeSH descriptors whose meaning is related to "Pharmaceutical Preparations".

Below are MeSH descriptors whose meaning is more specific than "Pharmaceutical Preparations".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pharmaceutical Preparations" by people in this website by year, and whether "Pharmaceutical Preparations" was a major or minor topic of these publications.

Bar chart showing 94 publications over 24 distinct years, with a maximum of 16 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
1999	3	0	3
2000	1	0	1
2002	2	1	3
2003	1	1	2
2005	2	0	2
2006	3	0	3
2007	2	4	6
2008	2	0	2
2009	1	1	2
2010	3	4	7
2011	1	1	2
2012	1	3	4
2013	2	3	5
2014	1	1	2
2015	2	1	3
2016	4	1	5
2017	2	1	3
2018	1	0	1
2019	2	1	3
2020	6	2	8
2021	15	1	16
2022	1	4	5
2023	0	4	4

Below are the most recent publications written about "Pharmaceutical Preparations" by people in Profiles.

D'Orazio J, Nelson L, Perrone J, Wightman R, Haroz R. Xylazine Adulteration of the Heroin-Fentanyl Drug Supply : A Narrative Review. Ann Intern Med. 2023 10; 176(10):1370-1376.

View in: PubMed
Golder S, Medaglio D, O'Connor K, Hennessy S, Gross R, Gonzalez Hernandez G. Reasons for Discontinuation or Change of Selective Serotonin Reuptake Inhibitors in Online Drug Reviews. JAMA Netw Open. 2023 07 03; 6(7):e2323746.

View in: PubMed
DeBoer CMT, Agrawal R, Rahimy E. Novel oral medications for retinal disease: an update on clinical development. Curr Opin Ophthalmol. 2023 May 01; 34(3):203-210.

View in: PubMed
Wong CI, Vannatta K, Gilleland Marchak J, Quade EV, Rodgers IM, Reid CM, Dandoy CE, Billett AL, Miller TP, Vaughn S, Daraiseh NM, Liu S, Carle AC, Walsh KE. Preventable harm because of outpatient medication errors among children with leukemia and lymphoma: A multisite longitudinal assessment. Cancer. 2023 04 01; 129(7):1064-1074.

View in: PubMed
Ferrandi EE, Bassanini I, Bertuletti S, Riva S, Tognoli C, Vanoni M, Monti D. Functional Characterization and Synthetic Application of Is2-SDR, a Novel Thermostable and Promiscuous Ketoreductase from a Hot Spring Metagenome. Int J Mol Sci. 2022 Oct 12; 23(20).

View in: PubMed
Schwedt TJ, Tassorelli C, Silberstein SD, Szperka CL, Kurth T, Pozo-Rosich P, Amin FM, Lipton RB, Dodick DW, Ashina M, Diener HC, Terwindt GM. Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition. Cephalalgia. 2022 10; 42(11-12):1099-1115.

View in: PubMed
Berg AR, Held MB, Jiao B, Swart E, Lakra A, Cooper HJ, Shah RP, Geller JA. Is the Direct Anterior Approach to THA Cost-effective? A Markov Analysis. Clin Orthop Relat Res. 2022 08 01; 480(8):1518-1532.

View in: PubMed
Crutcher MM, Baybutt TR, Kopenhaver JS, Snook AE, Waldman SA. Emerging drug targets for colon cancer: A preclinical assessment. Expert Opin Ther Targets. 2022 03; 26(3):207-216.

View in: PubMed
Thind M, McKindley DS, Reiffel JA, Naccarelli GV, Stewart J, Kowey PR. Predictors of dronedarone plasma drug concentrations and effect on atrial fibrillation/atrial flutter recurrence: Analyses from the EURIDIS and ADONIS studies. Clin Cardiol. 2022 Jan; 45(1):119-128.

View in: PubMed
Thangavel K, Lakshmikuttyamma A, Thangavel C, Shoyele SA. CD44-targeted, indocyanine green-paclitaxel-loaded human serum albumin nanoparticles for potential image-guided drug delivery. Colloids Surf B Biointerfaces. 2022 Jan; 209(Pt 1):112162.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement